Ignite Creation Date:
2024-05-06 @ 3:25 PM
Last Modification Date:
2024-10-26 @ 1:49 PM
Study NCT ID:
NCT04621188
Status:
RECRUITING
Last Update Posted:
2023-12-19
First Post:
2020-11-04
Brief Title:
Lorlatinib After Failure of First-line TKI in Patients with Advanced ROS1-positive NSCLC ALBATROS
Sponsor:
Organization:
Intergroupe Francophone de Cancerologie Thoracique